Posts

Face Lifting in Bald Male Patients

Face Lifting in Bald Male Patients

/in /by

Face Lifting in Bald Male Patients

Whether they choose the look, or genetics chooses it for them, some guys are embracing baldness. However, without a hairline, bald men who desire a facelift have a difficult time hiding their scars, which has always presented a challenge to plastic surgeons.

Statistics from the American Society of Plastic Surgeons reveal that more than 12,000 men had facelift surgery in 2018: an increase of three per cent from the previous year. A new study in the January issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS), proposes that a new shorter incision carried just a little above the top of the ear may be the solution.

In the conventional technique, the incision proceeds upward along the temple, in a location that’s easily hidden behind the hairline. But that’s not an option for many men, particularly those with hair loss. According to the American Hair Loss Association, two-thirds of men experience some degree of hair loss by age 35. By the age of 50, about 85 per cent of men have significantly thinner hair.

Rather than the traditional linear scar, the new incision changes direction at two or more points, following the shape of the front of the ear. Although somewhat shorter than the conventional incision, it still allows access to the deeper tissue layers for an effective, long-lasting facelift. While the shorter incision involves some excess skin, the technique includes steps for handling this problem.

The incision is strategically placed so that the outline of the ear helps to camouflage the scar, according to the report by Michele Pascali, MD, PhD, of University of Rome Tor Vergata, and colleagues. “Our proposed approach has proven to be reliably effective in obtaining virtually invisible scars and helps to meet the challenges of face-lifting in men who are bald,” Dr. Pascali comments.

Dr Pascali and colleagues evaluated the outcomes of 68 bald men (average age 55 years) who underwent a facelift procedure using the short-scar technique. At least one year after surgery, the men completed a questionnaire assessing their perceived results and satisfaction. The study also included an evaluation of before-and-after photographs by a three-member jury. Both assessments focused on the appearance, quality and extent of scars.

Outcomes were consistently good, as rated by both the patients and experts. The men’s average rating was 8.6 (out of 10) for satisfaction with overall facial appearance and 7.9 for satisfaction with scars. “None of the patients expressed regret about choosing to undergo this type of surgery,” the researchers write.

That was consistent with the panel of experts, whose ratings of scar quality were between 8 and 10 for all patients but one. None of the patients had major complications; three later underwent a minor procedure to improve the final scar quality.

As a growing number of men express interest in facelift surgery, “Baldness unquestionably represents a challenge,” Dr Pascali and coauthors write. They note that their paper is the first to focus on the unique challenges of performing facelifts on bald men.

They believe their technique also helps meet other requirements of men seeking facelift surgery, including their demand for the shortest possible recovery time. The short-scar technique “makes it possible to obtain excellent results that meet the expectations of bald male patients.”

The article reflects the speciality’s commitment to addressing the unique aspects of plastic surgery in men. Of more than 120,000 facelift procedures performed in 2018, about ten per cent were on men, according to ASPS statistics.

Plastic and Reconstructive Surgery® is published in the Lippincott portfolio by Wolters Kluwer.

About Plastic and Reconstructive Surgery

For more than 70 years, Plastic and Reconstructive Surgery® (http://www.prsjournal.com/) has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair and cosmetic surgery, as well as news on medico-legal issues.

About ASPS

The American Society of Plastic Surgeons is the largest organization of board-certified plastic surgeons in the world. Representing more than 7,000 physician members, the society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises more than 94 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada.

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2018 annual revenues of €4.3 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 18,600 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students with advanced clinical decision support, learning and research and clinical intelligence. For more information about our solutions, visit http://healthclarity.wolterskluwer.com and follow us on LinkedIn and Twitter @WKHealth.


Face Lifting in Bald Male Patients

Source

Previous Posts

Face Lifting in Bald Male Patients

Face Lifting in Bald Male Patients

/in /by

Face Lifting in Bald Male Patients

Whether they choose the look, or genetics chooses it for them, some guys are embracing baldness. However, without a hairline, bald men who desire a facelift have a difficult time hiding their scars, which has always presented a challenge to plastic surgeons.

Statistics from the American Society of Plastic Surgeons reveal that more than 12,000 men had facelift surgery in 2018: an increase of three per cent from the previous year. A new study in the January issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS), proposes that a new shorter incision carried just a little above the top of the ear may be the solution.

In the conventional technique, the incision proceeds upward along the temple, in a location that’s easily hidden behind the hairline. But that’s not an option for many men, particularly those with hair loss. According to the American Hair Loss Association, two-thirds of men experience some degree of hair loss by age 35. By the age of 50, about 85 per cent of men have significantly thinner hair.

Rather than the traditional linear scar, the new incision changes direction at two or more points, following the shape of the front of the ear. Although somewhat shorter than the conventional incision, it still allows access to the deeper tissue layers for an effective, long-lasting facelift. While the shorter incision involves some excess skin, the technique includes steps for handling this problem.

The incision is strategically placed so that the outline of the ear helps to camouflage the scar, according to the report by Michele Pascali, MD, PhD, of University of Rome Tor Vergata, and colleagues. “Our proposed approach has proven to be reliably effective in obtaining virtually invisible scars and helps to meet the challenges of face-lifting in men who are bald,” Dr. Pascali comments.

Dr Pascali and colleagues evaluated the outcomes of 68 bald men (average age 55 years) who underwent a facelift procedure using the short-scar technique. At least one year after surgery, the men completed a questionnaire assessing their perceived results and satisfaction. The study also included an evaluation of before-and-after photographs by a three-member jury. Both assessments focused on the appearance, quality and extent of scars.

Outcomes were consistently good, as rated by both the patients and experts. The men’s average rating was 8.6 (out of 10) for satisfaction with overall facial appearance and 7.9 for satisfaction with scars. “None of the patients expressed regret about choosing to undergo this type of surgery,” the researchers write.

That was consistent with the panel of experts, whose ratings of scar quality were between 8 and 10 for all patients but one. None of the patients had major complications; three later underwent a minor procedure to improve the final scar quality.

As a growing number of men express interest in facelift surgery, “Baldness unquestionably represents a challenge,” Dr Pascali and coauthors write. They note that their paper is the first to focus on the unique challenges of performing facelifts on bald men.

They believe their technique also helps meet other requirements of men seeking facelift surgery, including their demand for the shortest possible recovery time. The short-scar technique “makes it possible to obtain excellent results that meet the expectations of bald male patients.”

The article reflects the speciality’s commitment to addressing the unique aspects of plastic surgery in men. Of more than 120,000 facelift procedures performed in 2018, about ten per cent were on men, according to ASPS statistics.

Plastic and Reconstructive Surgery® is published in the Lippincott portfolio by Wolters Kluwer.

About Plastic and Reconstructive Surgery

For more than 70 years, Plastic and Reconstructive Surgery® (http://www.prsjournal.com/) has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair and cosmetic surgery, as well as news on medico-legal issues.

About ASPS

The American Society of Plastic Surgeons is the largest organization of board-certified plastic surgeons in the world. Representing more than 7,000 physician members, the society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises more than 94 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada.

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2018 annual revenues of €4.3 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 18,600 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students with advanced clinical decision support, learning and research and clinical intelligence. For more information about our solutions, visit http://healthclarity.wolterskluwer.com and follow us on LinkedIn and Twitter @WKHealth.


Face Lifting in Bald Male Patients

Source

Previous Posts

Dr. Rassael Discusses Hair Loss Recovery Procedures

Global Baldness Treatment Market

/in /by

Global Baldness Treatment Market – Industry Trends and Forecast to 2026

Global Baldness Treatment Market By Types (Androgenic Alopecia, Alopecia Areata, Alopecia Universalis, Alopecia Totalis and Others), Mechanism of Action (Potassium Channel Opener, Specific 5 Alpha-Reductase Inhibitor, Aldosterone Antagonist and Others), Drugs (Finasteride, Minoxidil, Dutasteride, Spironolactone and Others), Diagnosis (Blood Test, Pull Test, Scalp Biopsy and Light Microscopy) Treatment (Medication, Laser Therapy and Hair Transplant), Route of Administration (Oral and Topical), Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), End-Users (Hospitals, Homecare, Specialty Clinics and Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026
Market Analysis: Global Baldness Treatment Market

Global baldness treatment market is growing at a substantial CAGR of 6.74% in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017.

This rise in market value can be attributed to the increasing prevalence of hair loss across the world, changing lifestyle such as increased consumption of alcohol and tobacco, rising geriatric population, high level of stress or rising incidences of chronic diseases such as polycystic ovary syndrome (PCOS), cancer and rheumatoid arthritis are some factors driving the market growth.
Market Definition: Global Baldness Treatment Market

Baldness also known as alopecia, is a condition when hairs starts falling excessively from the scalp or elsewhere from the body. The reason for hair loss can be hereditary, hormonal changes, medical conditions or medications. Hereditary hair loss with age is the most common cause of baldness and hair loss is most commonly seen in men than women. Symptoms include sudden loosening of hairs from scalp, circular or patchy bald spots.

According to the Hair loss society, approximately 35 million men and 21 million women are suffering from hair loss worldwide. In men hair loss starts at an early age compared to women. At the age of 35 men losses 40% of their hairs and 70 % hair loss at the age of 80.

Market Drivers

Increasing prevalence of hair loss across the world is driving the market growth
Changing lifestyle such as increased consumption of alcohol and tobacco is accelerating the market growth
Growing emphasis on aesthetic appearances is also boosting the growth of this market
Rising geriatric population around the world is enhancing the market growth
High level of stress or rising incidences of chronic diseases such as polycystic ovary syndrome (PCOS), cancer and rheumatoid arthritis are fueling the market growth

Market Restraints

High cost of available hair transplantation treatment also hampers the market growth Restrictions on approved therapies is restricting the market growth
Side effects/allergic reactions are also acting as a major market restraint

Segmentation: Global Baldness Treatment Market

By Types

Androgenic Alopecia
Alopecia Areata
Alopecia Universalis
Alopecia Totalis
Others

By Mechanism of Action

Potassium Channel Opener
Specific 5 Alpha-Reductase Inhibitor
Aldosterone Antagonist
Others

By Drugs

Finasteride
Minoxidil
Dutasteride
Spironolactone
Others

By Diagnosis

Blood Test
Pull Test
Scalp Biopsy
Light Microscopy

By Treatment

Medication
Laser Therapy
Hair Transplant

By Route of Administration

Oral
Topical

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By End-Users

Hospitals
Homecare
Specialty Clinics

By Geography

North America
U.S.
Canada
Mexico
Europe
Germany
Italy
U.K.
France
Spain
Netherlands
Belgium
Switzerland
Turkey
Russia
Rest of Europe
Asia-Pacific
Japan
China
India
South Korea
Australia
Singapore
Malaysia
Thailand
Indonesia
Philippines
Rest of Asia Pacific
South America
Brazil
Rest of South America
Middle East & Africa
South Africa
Rest of Middle East & Africa

Key Developments in the Market

In September 2018, Pfizer Inc received Breakthrough Therapy designation from the U.S FDA for PF-06651600, an oral Janus kinase (JAK3) inhibitor. This drug is currently ongoing in phase ll clinical trial for the treatment of alopecia areata, an autoimmune disease that causes hair loss. This designation enables the company for priority review and will help in early approval of the drug

In January 2018, HCell Inc received the Orphan Drug designation from the U.S FDA for HC017AA, an investigational new drug for the treatment of alopecia areata, an autoimmune disease that causes hair loss. This designation enables the company for 7 years of exclusive U.S. marketing of HC017AA on approval, including tax credits for qualified clinical research costs, and a waiver of the prescription drug user fee act (PDUFA) filing fees

Competitive Analysis:

Global baldness treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of baldness treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Players:

The key market players in the global baldness treatment market are Pfizer Inc, DAIICHI SANKYO COMPANY, LIMITED, Johnson & Johnson Services, Inc, Cipla Inc, Merck & Co., Inc, Sun Pharmaceutical Industries Ltd, Dr. Reddy’s Laboratories Ltd, Church & Dwight Co., Inc, Vitabiotics Ltd, DR. WOLFF-GRUPPE GMBH, Nanogen, Alès Groupe, Histogen Inc, Concert Pharmaceuticals, Inc, Aclaris Therapeutics, Inc, HCell Inc, GlaxoSmithKline plc among others.

Research Methodology: Global Baldness Treatment Market:

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents:

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technical Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report:

Current and future of global baldness treatment market outlook in the developed and emerging markets.
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.

Global Baldness Treatment Market – Industry Trends and Forecast to 2026

Source

Previous Posts

theradome hair loss

Baldness Treatment Market

/in /by

Baldness Treatment Market: The Next Booming Segment in the World| Pfizer, Nanogen, Alès Groupe, Histogen, Concert Pharmaceuticals

Global baldness treatment market is growing at a substantial CAGR of 6.74% in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the increasing prevalence of hair loss across the world, changing lifestyle such as increased consumption of alcohol and tobacco, rising geriatric population, high level of stress or rising incidences of chronic diseases such as polycystic ovary syndrome (PCOS), cancer and rheumatoid arthritis are some factors driving the market growth.
Market Definition: Global Baldness Treatment Market

Baldness also known as alopecia, is a condition when hairs starts falling excessively from the scalp or elsewhere from the body. The reason for hair loss can be hereditary, hormonal changes, medical conditions or medications. Hereditary hair loss with age is the most common cause of baldness and hair loss is most commonly seen in men than women. Symptoms include sudden loosening of hairs from scalp, circular or patchy bald spots.

According to the Hair loss society, approximately 35 million men and 21 million women are suffering from hair loss worldwide. In men hair loss starts at an early age compared to women. At the age of 35 men losses 40% of their hairs and 70 % hair loss at the age of 80.

Market Drivers

Increasing prevalence of hair loss across the world is driving the market growth
Changing lifestyle such as increased consumption of alcohol and tobacco is accelerating the market growth
Growing emphasis on aesthetic appearances is also boosting the growth of this market
Rising geriatric population around the world is enhancing the market growth
High level of stress or rising incidences of chronic diseases such as polycystic ovary syndrome (PCOS), cancer and rheumatoid arthritis are fueling the market growth

Market Restraints

High cost of available hair transplantation treatment also hampers the market growth Restrictions on approved therapies is restricting the market growth
Side effects/allergic reactions are also acting as a major market restraint

Segmentation: Global Baldness Treatment Market

By Types

Androgenic Alopecia
Alopecia Areata
Alopecia Universalis
Alopecia Totalis
Others

By Mechanism of Action

Potassium Channel Opener
Specific 5 Alpha-Reductase Inhibitor
Aldosterone Antagonist
Others

By Drugs

Finasteride
Minoxidil
Dutasteride
Spironolactone
Others

By Diagnosis

Blood Test
Pull Test
Scalp Biopsy
Light Microscopy

By Treatment

Medication
Laser Therapy
Hair Transplant

By Route of Administration

Oral
Topical

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By End-Users

Hospitals
Homecare
Specialty Clinics

By Geography

North America
U.S.
Canada
Mexico
Europe
Germany
Italy
U.K.
France
Spain
Netherlands
Belgium
Switzerland
Turkey
Russia
Rest of Europe
Asia-Pacific
Japan
China
India
South Korea
Australia
Singapore
Malaysia
Thailand
Indonesia
Philippines
Rest of Asia Pacific
South America
Brazil
Rest of South America
Middle East & Africa
South Africa
Rest of Middle East & Africa

Key Developments in the Market

In September 2018, Pfizer Inc received Breakthrough Therapy designation from the U.S FDA for PF-06651600, an oral Janus kinase (JAK3) inhibitor. This drug is currently ongoing in phase ll clinical trial for the treatment of alopecia areata, an autoimmune disease that causes hair loss. This designation enables the company for priority review and will help in early approval of the drug

In January 2018, HCell Inc received the Orphan Drug designation from the U.S FDA for HC017AA, an investigational new drug for the treatment of alopecia areata, an autoimmune disease that causes hair loss. This designation enables the company for 7 years of exclusive U.S. marketing of HC017AA on approval, including tax credits for qualified clinical research costs, and a waiver of the prescription drug user fee act (PDUFA) filing fees

Competitive Analysis:

Global baldness treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of baldness treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Players:

The key market players in the global baldness treatment market are Pfizer Inc, DAIICHI SANKYO COMPANY, LIMITED, Johnson & Johnson Services, Inc, Cipla Inc, Merck & Co., Inc, Sun Pharmaceutical Industries Ltd, Dr. Reddy’s Laboratories Ltd, Church & Dwight Co., Inc, Vitabiotics Ltd, DR. WOLFF-GRUPPE GMBH, Nanogen, Alès Groupe, Histogen Inc, Concert Pharmaceuticals, Inc, Aclaris Therapeutics, Inc, HCell Inc, GlaxoSmithKline plc among others.

Research Methodology: Global Baldness Treatment Market:

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents:

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technical Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report:

Current and future of global baldness treatment market outlook in the developed and emerging markets.
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.

Baldness Treatment Market: The Next Booming Segment in the World| Pfizer, Nanogen, Alès Groupe, Histogen, Concert Pharmaceuticals

Source

Previous Posts

Addressing baldness in women

Addressing baldness in women

/in /by

Addressing baldness in women

The sight of hair loss can be very worrying for a woman, at times making her lose confidence. Greater the stress, greater the hair loss. Pattern baldness is a serious concern among women.
Addressing a workshop on causes of hair loss among women, Dr Premalatha, Dermatologist of Hairline International Hair & Skin Clinic talks about hormone induced hair loss in women and the myths surrounding hair transplants.
Q. Hormonal changes are considered to cause baldness in women. What kind of hormonal changes and how does this happen?
Among the various causes of hairloss, hormonal variation is one important factor. It concerns changes in the level of androgens, the male hormones.
After reaching menopause, women find hair on their head getting thinner while hair on their face gets coarser.
Women with FPHL(Female pattered hairloss) are more likely to show signs of virilization and some reveal hyperandrogenemia .
Too much androgen brings in abnormal new hair growth, such as on the face, between the belly button and pubic area.
One can see these signs by observing changes in menstrual periods, followed by an enlargement of the clitoris.
Another sign would be new acne formations. Procedures such blood tests can diagnose the hormone variation in women with hairloss. Another factor leading to hair loss is too much or too little of Thyroid hormone. The danger associated with female pattern baldness is that hair loss is permanent if not treated.
Q. Can you comment about the condition of hair in women during the time of pregnancy and delivery?
After pregnancy and delivery, a phenomenon known as Telogen Effluvium is observed. It occurs due to many other reasons as well, like drastic weight loss, major surgery or high levels of stress.
This phenomenon involves shedding of large amounts of hair each day, during shampooing, styling or brushing.
Women experiencing the phenomenon witness large amounts of hair being shed usually 6 weeks to 3 months after a stressful event, like a pregnancy.
At the peak of this condition, handfuls of hair may be lost. In order to find evidence to diagnose someone with Telogen Effluvium, doctors may look for small club-shaped bulbs on the fallen hair roots.
The presence of the bulbs indicates that the hair has gone through a complete cycle of growth, suggesting the cycle may have sped up due to stress, because of pregnancy. The only thing one can do when experiencing Telogen Effluvium is wait until the hair loss slows down.
Also other contributing factors such as stress related problems can be tackled by reducing anxiety through meditation and other recommended ways.
Q. The obvious answer to chronic hair loss here is hair transplant. Can you tell us a bit about how it works?
Use of topical medication and PRP (Platelet rich plama) can help them in initial stages of baldness where as advance stages require hair transplant.
Hair transplant is a method of hair redistribution wherein hair is removed from areas on the scalp where hair is thicker and placed on areas which are balding.
Minor scars may appear on the areas where hair is removed, but the end result is permanent. Other solutions such as a change in hairstyle, or hair weaving, can also be utilized to improve appearance.
Very few people however have the courage to undergo the treatment, even though latest researches show that market for hair transplantation is growing rapidly. Many myths surround this treatment, preventing people suffering from pattern balding from giving it a try.
Q. Can we discuss some of them?
The method of hair transplant is holistic and all round yields good results. But people have false notions about it. A common myth is that old people cannot undergo treatment, preventing old people from undergoing it. Age has nothing to do with it.
The texture and quality of your existing hair determines whether or not you are suitable for it.
Also, some people believe hair transplant is only possible at the initial stages of hair loss. On the contrary, it is actually the opposite. It is in fact more difficult to predict in the initial stages the extent of hair loss and whether you require treatment. It makes more sense to go to the physician when hair loss gets stable.
The treatment does not give immediate results. The patient generally sees results after about 8 months, and the head filling with hair within 9-12 months.
Another myth is that surgery affects the brain. There is no connection whatsoever. Surgery involves only the skin of your scalp. There is no contact with any part of the brain. Lastly, a common misconception is that surgery leaves no scars. This is untrue.
Every hair restoration technique leaves scars on the scalp. Surgery however reduces these scars to a formation of multiple dots. However, scarring is minimal and almost invisible even if you are completely bald.

Q. Concerns exist on affordability of the surgery. What is your comment?
Cost of surgery depends on a number of factors, especially the number of grafts to be transplanted. It can be a little costly, but definitely affordable. Most hair transplant clinics offer options of paying in instalments.
About Hairline International Hair and Skin Clinic
Hairline International Hair and Skin Clinic have been pioneers in the medical management of hair and skin. Hairline International brings state-of-the-art international procedures, machinery and treatment packages to deal with hair, skin and beauty issues across the spectrum for men and women.
Hairline has medical as well as beauty professionals for carrying out all procedures.at their four centres in Bangalore.
Shaved Head Challenge

Shaved Head Challenge

/in /by

The Leucan Shaved Head Challenge Unveils a Brand New Look! – It’s the Official Kick-Off of the 2016 Edition

Leucan launches today the 2016 edition of the Leucan Shaved Head Challenge presented by PROXIM.

This year, in an effort to return the focus on the beauty of the action taken by thousands of participants each year, the Association is placing them at the heart of its new campaign.

In this way, Leucan highlights the generosity of the difficult yet gratifying choice participants make of having their heads shaved to raise funds for cancer-stricken children and their families.

To put the spotlight fully on the participants and showcase the pride they feel after their Challenge, the ad designers insisted on actively involving a few of them in this campaign.

“Experiencing the Challenge is an incredible opportunity, but it’s mostly very rewarding to know that I will inspire others to take action,” says Brontë Poiré-Prest, one of the participants featured in this campaign who took on the Challenge in 2015.

The Leucan Shaved Head Challenge Unveils a Brand New Look!

“Designed generously by TAM-TAM\TBWA, this new integrated campaign, which will be rolled out on television and radio, as well as in print, billboards, social media and the web, is sure to raise awareness of the cause and of the event,” explains Lysanne Groulx, Marketing, Communications and Social Networks Director.

For the TV commercial, the Association looked once again to an outstanding director from Quebec, this time collaborating with Rafaël Ouellet, who most notably directed the TV series Nouvelle adresse and the feature film Camion.

The ad can be viewed online on Leucan’s YouTube channel.

Throughout the year and across the province, over 60 shaving sites will be held by Leucan, in addition to the many Challenges hosted by companies, organizations and educational institutions.

We also urge people to pick a time and place of their choice and to create their own Personalized Challenge. As usual, there will be a provincial Challenge day set out for May 29, 2016.

For this edition, the official shaving site will be at Place Versailles. To take on the Challenge or sponsor a participant, please visit shavedheadchallenge.com.

Finally, Leucan wishes to thank PROXIM, the new generous presenting sponsor of the Challenge, Mia for selling its exclusive earrings of hope for a second year, with proceeds going to Leucan, as well as the humorist Dominic Paquet, the Challenge’s provincial spokesperson for a fifth year in a row.

About the Challenge

The Leucan Shaved Head Challenge is a major fundraiser of Leucan that engages the community in a spirit of solidarity to provide services to cancer-stricken children and their families as well as providing financial support to clinical research.

It is also a gesture of support for children whose body image is altered when chemotherapy provokes hair loss.

About Leucan

For more than 35 years, Leucan has been supporting cancer-stricken children and their families from the day of diagnosis through every stage of the disease.

As a loyal ally of hundreds of families and thousands of members across Quebec, the Association provides specific and personalized services delivered by a qualified team with a cutting edge expertise.

Leucan also funds clinical research and the Leucan Information Centre. With its many offices, Leucan is present throughout Quebec.

About PROXIM

PROXIM will be celebrating its 10th anniversary in 2016, and was created following the consolidation of independent pharmacist-owners.

With over 250 pharmacies throughout Québec, pharmacist-owners affiliated with PROXIM are leading health professionals in their community. Their priority is to provide specialized and customized support to their patients for improved health.

Source

Samumed-hair loss trial

New Baldness Cure

/in /by

New ‘Baldness Cure’ Makes Men Regrow Hair In Human Trial

A new solution which men rub into their heads is ‘showing promise’ as a treatment for male pattern baldness – with volunteers regrowing hair after using the drug.

Samumed,  LLC, a  leader  in  tissue  regeneration,  announced that it will present clinical data on a small molecule SM04554, an investigational new drug) for potential treatment of androgenetic alopecia

In preclinical in vivo studies, SM04554 has been shown to regenerate new hair follicles and increase hair
count in multiple a nimal models.

The company has finished a Phase I trial and is about to complete its Phase  II  trial  with  the  same  potential  AGA  treatment.

The drug has been tested on 300 volunteers, who were closely monitored as they used different concentrations.

And for once, the drug is actually working on humans, rather than mice or undersea worms or something equally irrelevant.

The drug – code named SMO4554 – is made by San Diego biotech start-up Samumed, and will go into larger human trials shortly.

Samumed says, ‘SM04554 appeared to be safe and well-tolerated. Over the 135-day study, both groups showed an increase in hair count and hair density, objectively measured by macrophotography.’

The results are ‘preliminary’, Forbes reports – but 300 men who took it reported growing new hairs in a one-square-centimetre patch of their head.

The drug seems strongly dependent on dose, Samumed reported – and says that in its animal trials, there seemed to be ‘Goldilocks’ zone where the effects worked best.

Source

spexhair and baldness

Spencer Stevenson of Spexhair on How To Cure Baldness

/in /by

Spencer Stevenson of Spexhair.com Interviewed By The Telegraph Newspaper on How To Cure Baldness

Spencer Stevenson, the owner of the popular hair loss help website spexhair.com, was interviewed by Peter Lloyd from the prestigious newspaper The Telegraph giving his insights and knowledge on how to treat male pattern baldness through proven treatments.

In the article published on the 23rd of November by the Telegraph titled ‘How to cure baldness (without losing your money as well as your hair)’, Spencer discusses the growing amount of men wanting to treat their hair loss and more importantly the actual methods which are proven to work.

Spencer, when asked about the best way to start thinking about treating hair loss, had the following to say: “The key, it seems, it to stabilise hair loss before stepping into a transplant clinic.

The only products that work in my experienced opinion are a combination of 1mg Finasteride (Propecia) and a topical application of Minoxidil (Rogaine), with occasional use of Nizoral.

Everything else, including trendy caffeinated shampoos, might keep the scalp clean or promote follicle health, but they do nothing to stop the hair being attacked by DHT, which is crucial.”

The industry according to Spencer is growing by 35% over the past two years and turns over £1.5 Billion. Average Hair transplants cost around £5,000-£7,000 depending on the number of grafts being transplanted and the clinic.

Spencer further revealed what not to waste any money on when it comes to treating hair loss which were:

Laser Caps/combs, herbal supplements and caffeine shampoos.

The article published by The Telegraph is among several interviews Spencer Stevenson has given over the past few years on the topic of hair loss.

Those interested can read more about Spencer Stevenson and his media coverage by visiting his hair loss website spexhair.com.